A Phase 1 interventional study of Syntocinon (Oxytocin) nasal spray and Placebo in Healthy Volunteers, sponsored by University of Zurich. Completed at 1 site in Switzerland. Open to participants aged 21 Years to 45 Years. Per ClinicalTrials.gov, last updated 2014-02-25.
Sponsored by University of Zurich · Phase 1, Interventional, and Treatment
effects of intranasal oxytocin and couple interaction on wound healing.
University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion criteria:
Exclusion criteria: pregnancy
Drug: Syntocinon (Oxytocin) nasal spray
Drug: Placebo
two-times daily self-administration of nasal spray containing active substance (oxytocin) during five days after wounding.
two-times daily self-administration of nasal spray containing placebo during five days after wounding.
wound size
wound healing process within seven days after wounding
Time frame: seven days
This study is completed, as verified in Feb 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Zurich